Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has 68 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 2,077,317 | 1,376,325 | 196.34% | $15,290.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 930,000 | 930,000 | 0.00% | $6,844,800.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 889,575 | 889,575 | 0.00% | $6,547,272.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 559,619 | 151,397 | 37.09% | $4,118,796.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 544,554 | 517,297 | 1,897.85% | $4,007,918.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 440,000 | 440,000 | 0.00% | $3,238,400.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 421,322 | 0 | 0.00% | $3,100,930.00 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 31 Dec, 2025 | 310,020 | 310,020 | 0.00% | $2,281,747.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 303,370 | 303,370 | 0.00% | $2,232,803.00 |
| Exome Asset Management LLC | 31 Dec, 2025 | 295,541 | 295,541 | 0.00% | $2,175,182.00 |
| Ameriprise Financial Inc | 31 Dec, 2025 | 276,881 | 276,881 | 0.00% | $2,037,844.00 |
| Boxer Capital Management, LLC | 31 Dec, 2025 | 252,536 | 252,536 | 0.00% | $1,858,665.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 247,558 | 15,607 | 6.73% | $1,822,026.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 187,734 | 94,445 | 101.24% | $1,381,872.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 148,793 | 148,793 | 0.00% | $1,095,116.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 147,698 | 112,359 | 317.95% | $1,087,057.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 144,628 | 144,628 | 0.00% | $1,064,462.00 |
| Catalio Capital Management, LP | 31 Dec, 2025 | 142,984 | 0 | 0.00% | $1,052,362.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 134,566 | 0 | 0.00% | $990,406.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 128,451 | 0 | 0.00% | $945,400.00 |